Webinar: Building Fit-for-Purpose Oncology Real-World Evidence in JapanReal-World EvidenceVideoWebinarLife sciencesHEOR / RWEReal-World DataJapan Publications
Partners in progress: A conversation with Dr. Nathan Littlejohn on OncoEMR® for urologyPoint of careCustomer storiesUrology
Can we trust AI-generated RWD? A systematic validation approach in prostate cancerReal-World EvidencePublicationsArtificial intelligenceData QualityReal-World Data
Webinar: An HEOR playbook for oncology RWE and AI use to support European HTAReal-World EvidenceWebinarLife sciencesHEOR / RWEReal-World Data
What we’ve learned from the first EU joint clinical assessments: Takeaways from a panel of RWE and HTA expertsReal-World EvidenceLife sciencesHEOR / RWEReal-World DataMultinational data
One Standard, Many Markets: What FDA, EMA, and PMDA Actually Agree OnReal-World EvidenceRegulatoryLife sciencesReal-World Data
A conversation with Dr. Ronac Mamtani on the evidence that moves oncology forwardPoint of careHealth SystemsAcademicsReal-World Data
ASCO 2026: Translating oncology innovation into real-world impactReal-World EvidenceLife sciencesReal-World Data
Rewriting the real-world evidence playbook for clinical developmentReal-World EvidenceTrial designArtificial intelligenceData QualityLife sciencesReal-World DataClinical development